Novacea's IPO

Novacea raised a round of funding on May 10, 2006. Investors include Public.

Novacea is a biopharmaceutical company that had been focused on in-licensing, developing and commercializing novel cancer therapies. Novacea has two product candidates, including AsentarTM, which had …

Articles about Novacea's IPO: